Order Article Reprints

Tramsen L, Bochennek K, Sparber-Sauer M, Salzmann-Manrique E, Scheer M, Dantonello T, Borkhardt A, Dirksen U, Thorwarth A, Greiner J, et al. Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. Cancers. 2023; 15(7):2050. https://doi.org/10.3390/cancers15072050

Tramsen, Lars, Konrad Bochennek, Monika Sparber-Sauer, Emilia Salzmann-Manrique, Monika Scheer, Tobias Dantonello, Arndt Borkhardt, Uta Dirksen, Anne Thorwarth, Jeanette Greiner, and et al. 2023. "Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials" Cancers 15, no. 7: 2050. https://doi.org/10.3390/cancers15072050

Tramsen, L., Bochennek, K., Sparber-Sauer, M., Salzmann-Manrique, E., Scheer, M., Dantonello, T., Borkhardt, A., Dirksen, U., Thorwarth, A., Greiner, J., Ebinger, M., Weclawek-Tompol, J., Ladenstein, R., Ljungman, G., Hallmen, E., Lehrnbecher, T., Koscielniak, E., & Klingebiel, T. (2023). Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. Cancers, 15(7), 2050. https://doi.org/10.3390/cancers15072050